Literature DB >> 28050866

MicroRNA-638 inhibits cell proliferation by targeting suppress PIM1 expression in human osteosarcoma.

Xiao-Xu Wang1, Jue Liu2, Yi-Min Tang3, Liang Hong1, Zhi Zeng1, Guang-Hua Tan4.   

Abstract

MicroRNAs (miRNAs) are a type of small noncoding RNAs that often play important roles in carcinogenesis, but the carcinogenic mechanism of miRNAs is still unclear. This study will investigate the functions and the mechanism of miR-638 in osteosarcoma (OS). The expression of miR-638 in OS and the DNA copy number of miR-638 were detected by real-time PCR. The effect of miR-638 on cell proliferation was measured by CCK8 assay. Different assays, including bioinformatics algorithms, luciferase report assay, and Western blotting, were used to identify the target gene proviral integration site for Moloney murine leukemia virus 1 (PIM1) of miR-638 in OS. The expression of PIM1 in clinical OS tissues was also validated by immunohistochemical assay. From this research, we found that miR-638 was downregulated in OS tissues compared with corresponding noncancerous tissues (NCTs), and the DNA copy number of miR-638 was lower in OS than in NCTs, which may induce the corresponding downregulation of miR-638 in OS. Ectopic expression of miR-638 inhibited OS cell growth in vitro. Subsequently, we identified that PIM1 is the downstream target gene of miR-638 in OS cells, and silencing PIM1 expression phenocopied the inhibitory effect of miR-638 on OS cell proliferation. Furthermore, we observed that PIM1 was overexpressed in OS tissues, and high expression of PIM1 in OS predicted poor overall survival. In summary, we revealed that miR-638 functions as a tumor suppressor through inhibiting PIM1 expression in OS.

Entities:  

Keywords:  Osteosarcoma; PIM1; Proliferation; miR-638

Year:  2017        PMID: 28050866     DOI: 10.1007/s13277-016-5379-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  39 in total

1.  miR-155 promotes the growth of osteosarcoma in a HBP1-dependent mechanism.

Authors:  Xiaohui Sun; Xiaolin Geng; Jun Zhang; Hongxing Zhao; Ying Liu
Journal:  Mol Cell Biochem       Date:  2015-02-10       Impact factor: 3.396

Review 2.  MicroRNAs are involved in the self-renewal and differentiation of cancer stem cells.

Authors:  Zheng-ming Wang; Wen-jun Du; Gary A Piazza; Yaguang Xi
Journal:  Acta Pharmacol Sin       Date:  2013-10-14       Impact factor: 6.150

3.  miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma.

Authors:  Lei Chen; Qing Wang; Guo-dong Wang; Hua-song Wang; Yong Huang; Xi-ming Liu; Xian-hua Cai
Journal:  FEBS Lett       Date:  2013-03-15       Impact factor: 4.124

Review 4.  PIM1 kinase as a target for cancer therapy.

Authors:  Anna Lena Merkel; Eric Meggers; Matthias Ocker
Journal:  Expert Opin Investig Drugs       Date:  2012-03-04       Impact factor: 6.206

5.  Copy number variable microRNAs in schizophrenia and their neurodevelopmental gene targets.

Authors:  William Warnica; Daniele Merico; Gregory Costain; Simon E Alfred; John Wei; Christian R Marshall; Stephen W Scherer; Anne S Bassett
Journal:  Biol Psychiatry       Date:  2014-05-29       Impact factor: 13.382

Review 6.  Current concepts on pathogenesis and biology of metastatic osteosarcoma tumors.

Authors:  Sławomir Poletajew; Lukasz Fus; Aleksander Wasiutyński
Journal:  Ortop Traumatol Rehabil       Date:  2011 Nov-Dec

7.  Clinical and therapeutic relevance of PIM1 kinase in gastric cancer.

Authors:  Benedict Yan; Ee Xuan Yau; Sanjay Samanta; Chee Wee Ong; Kol Jia Yong; Lai Kuan Ng; Bhaskar Bhattacharya; Kiat Hon Lim; Richie Soong; Khay Guan Yeoh; Niantao Deng; Patrick Tan; Yulin Lam; Manuel Salto-Tellez
Journal:  Gastric Cancer       Date:  2011-10-13       Impact factor: 7.370

8.  Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells.

Authors:  J Wang; P D Anderson; W Luo; D Gius; M Roh; S A Abdulkadir
Journal:  Oncogene       Date:  2011-08-22       Impact factor: 9.867

9.  miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy.

Authors:  Animesh Bhattacharya; Ulf Schmitz; Yvonne Raatz; Madeleine Schönherr; Tina Kottek; Marianne Schauer; Sandra Franz; Anja Saalbach; Ulf Anderegg; Olaf Wolkenhauer; Dirk Schadendorf; Jan C Simon; Thomas Magin; Julio Vera; Manfred Kunz
Journal:  Oncotarget       Date:  2015-02-20

10.  miR-638 mediated regulation of BRCA1 affects DNA repair and sensitivity to UV and cisplatin in triple-negative breast cancer.

Authors:  Xiaohui Tan; Jin Peng; Yebo Fu; Shejuan An; Katayoon Rezaei; Sana Tabbara; Christine B Teal; Yan-gao Man; Rachel F Brem; Sidney W Fu
Journal:  Breast Cancer Res       Date:  2014-09-17       Impact factor: 6.466

View more
  9 in total

1.  Expression of microRNA 638 and sex-determining region Y-box 2 in hepatocellular carcinoma: Association between clinicopathological features and prognosis.

Authors:  Weikang Ye; Jieke Li; Guan Fang; Xiupeng Cai; Yan Zhang; Chaojun Zhou; Lei Chen; Wenjun Yang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

Review 2.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

3.  MicroRNA-431-5p Inhibits the Tumorigenesis of Osteosarcoma Through Targeting PANX3.

Authors:  Shengliang Sun; Lei Fu; Gen Wang; Jianli Wang; Liping Xu
Journal:  Cancer Manag Res       Date:  2020-09-08       Impact factor: 3.989

4.  Identification of Four Oxidative Stress-Responsive MicroRNAs, miR-34a-5p, miR-1915-3p, miR-638, and miR-150-3p, in Hepatocellular Carcinoma.

Authors:  Yong Wan; Ruixia Cui; Jingxian Gu; Xing Zhang; Xiaohong Xiang; Chang Liu; Kai Qu; Ting Lin
Journal:  Oxid Med Cell Longev       Date:  2017-07-24       Impact factor: 6.543

5.  NAIF1 suppresses osteosarcoma progression and is regulated by miR-128.

Authors:  Daliang Kong; Zhe Zhang
Journal:  Cell Biochem Funct       Date:  2018-11-08       Impact factor: 3.685

6.  MicroR-542-3p can mediate ILK and further inhibit cell proliferation, migration and invasion in osteosarcoma cells.

Authors:  Wei Cai; Yong Xu; Wenshan Zuo; Zhen Su
Journal:  Aging (Albany NY)       Date:  2019-01-11       Impact factor: 5.682

7.  MiR-638 Repressed Vascular Smooth Muscle Cell Glycolysis by Targeting LDHA.

Authors:  Shiyuan Chen; Hu Chen; Chaowen Yu; Ran Lu; Tao Song; Xiaogao Wang; Wenbo Tang; Yong Gao
Journal:  Open Med (Wars)       Date:  2019-12-31

8.  Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis.

Authors:  Lixia Hu; Mengqin Huang; Qianqian Yuan; Fanliang Kong
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.817

9.  MicroRNA-638 inhibits cell growth and tubule formation by suppressing VEGFA expression in human Ewing sarcoma cells.

Authors:  Xin Zhou; Jiajun Chen; Qianren Xiao; Tengyu Wang; Yu Yu; Bo Li; Gaohai Shao; Yunyun Li; Zhongzu Zhang
Journal:  Biosci Rep       Date:  2018-01-19       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.